These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17127275)

  • 1. Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia.
    Ying W; Wei G; Wang D; Wang Q; Tang X; Shi J; Zhang P; Lu H
    Front Biosci; 2007 Jan; 12():2728-34. PubMed ID: 17127275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury.
    Wei G; Wang D; Lu H; Parmentier S; Wang Q; Panter SS; Frey WH; Ying W
    Front Biosci; 2007 Sep; 12():4986-96. PubMed ID: 17569625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia.
    Takahashi K; Pieper AA; Croul SE; Zhang J; Snyder SH; Greenberg JH
    Brain Res; 1999 May; 829(1-2):46-54. PubMed ID: 10350529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia.
    Zheng C; Han J; Xia W; Shi S; Liu J; Ying W
    Neurosci Lett; 2012 Mar; 512(2):67-71. PubMed ID: 22260797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia.
    Nagayama T; Simon RP; Chen D; Henshall DC; Pei W; Stetler RA; Chen J
    J Neurochem; 2000 Apr; 74(4):1636-45. PubMed ID: 10737622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
    Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
    Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
    Crome O; Doeppner TR; Schwarting S; Müller B; Bähr M; Weise J
    J Neurosci Res; 2007 Jun; 85(8):1734-43. PubMed ID: 17455321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
    Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation.
    Lo EH; Bosque-Hamilton P; Meng W
    Stroke; 1998 Apr; 29(4):830-6. PubMed ID: 9550519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
    Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
    J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
    Jiao Y; Li G
    Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
    Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
    Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat.
    Lu XC; Massuda E; Lin Q; Li W; Li JH; Zhang J
    Brain Res; 2003 Jul; 978(1-2):99-103. PubMed ID: 12834903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
    Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
    J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the brain following cerebral ischemia through the attenuation of PARP-1-induced neurovascular unit damage in rats.
    Zhang R; Tang S; Huang W; Liu X; Li G; Chi H; Zhu M; Tang J
    Brain Res; 2015 Oct; 1624():9-18. PubMed ID: 26220474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
    Sun M; Zhao Y; Gu Y; Xu C
    Amino Acids; 2012 May; 42(5):1735-47. PubMed ID: 21409386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.